291 related articles for article (PubMed ID: 31813626)
1. Associations between cerebral blood flow and structural and functional brain imaging measures in individuals with neuropsychologically defined mild cognitive impairment.
Kim CM; Alvarado RL; Stephens K; Wey HY; Wang DJJ; Leritz EC; Salat DH
Neurobiol Aging; 2020 Feb; 86():64-74. PubMed ID: 31813626
[TBL] [Abstract][Full Text] [Related]
2. Differential Associations of Diastolic and Systolic Pressures With Cerebral Measures in Older Individuals With Mild Cognitive Impairment.
Shokouhi M; Qiu D; Samman Tahhan A; Quyyumi AA; Hajjar I
Am J Hypertens; 2018 Nov; 31(12):1268-1277. PubMed ID: 30052724
[TBL] [Abstract][Full Text] [Related]
3. Cerebral blood flow is an earlier indicator of perfusion abnormalities than cerebral blood volume in Alzheimer's disease.
Lacalle-Aurioles M; Mateos-Pérez JM; Guzmán-De-Villoria JA; Olazarán J; Cruz-Orduña I; Alemán-Gómez Y; Martino ME; Desco M
J Cereb Blood Flow Metab; 2014 Apr; 34(4):654-9. PubMed ID: 24424381
[TBL] [Abstract][Full Text] [Related]
4. The effect of white matter signal abnormalities on default mode network connectivity in mild cognitive impairment.
Wang Z; Williams VJ; Stephens KA; Kim CM; Bai L; Zhang M; Salat DH
Hum Brain Mapp; 2020 Apr; 41(5):1237-1248. PubMed ID: 31742814
[TBL] [Abstract][Full Text] [Related]
5. Regional hyperperfusion in older adults with objectively-defined subtle cognitive decline.
Thomas KR; Osuna JR; Weigand AJ; Edmonds EC; Clark AL; Holmqvist S; Cota IH; Wierenga CE; Bondi MW; Bangen KJ;
J Cereb Blood Flow Metab; 2021 May; 41(5):1001-1012. PubMed ID: 32615887
[TBL] [Abstract][Full Text] [Related]
6. White matter signal abnormality quality differentiates mild cognitive impairment that converts to Alzheimer's disease from nonconverters.
Lindemer ER; Salat DH; Smith EE; Nguyen K; Fischl B; Greve DN;
Neurobiol Aging; 2015 Sep; 36(9):2447-57. PubMed ID: 26095760
[TBL] [Abstract][Full Text] [Related]
7. Resting Cerebral Blood Flow After Exercise Training in Mild Cognitive Impairment.
Alfini AJ; Weiss LR; Nielson KA; Verber MD; Smith JC
J Alzheimers Dis; 2019; 67(2):671-684. PubMed ID: 30636734
[TBL] [Abstract][Full Text] [Related]
8. Relationships Between Lower Olfaction and Brain White Matter Lesions in Elderly Subjects with Mild Cognitive Impairment.
Heinrich J; Vidal JS; Simon A; Rigaud AS; Hanon O; Epelbaum J; Viollet C; Duron E
J Alzheimers Dis; 2018; 61(3):1133-1141. PubMed ID: 29332036
[TBL] [Abstract][Full Text] [Related]
9. Complexity analysis of cortical surface detects changes in future Alzheimer's disease converters.
Ruiz de Miras J; Costumero V; Belloch V; Escudero J; Ávila C; Sepulcre J
Hum Brain Mapp; 2017 Dec; 38(12):5905-5918. PubMed ID: 28856799
[TBL] [Abstract][Full Text] [Related]
10. The Disconnection Hypothesis in Alzheimer's Disease Studied Through Multimodal Magnetic Resonance Imaging: Structural, Perfusion, and Diffusion Tensor Imaging.
Lacalle-Aurioles M; Navas-Sánchez FJ; Alemán-Gómez Y; Olazarán J; Guzmán-De-Villoria JA; Cruz-Orduña I; Mateos-Pérez JM; Desco M
J Alzheimers Dis; 2016; 50(4):1051-64. PubMed ID: 26890735
[TBL] [Abstract][Full Text] [Related]
11. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
Tosun D; Schuff N; Jagust W; Weiner MW;
Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
[TBL] [Abstract][Full Text] [Related]
12. Molecular imaging of serotonin degeneration in mild cognitive impairment.
Smith GS; Barrett FS; Joo JH; Nassery N; Savonenko A; Sodums DJ; Marano CM; Munro CA; Brandt J; Kraut MA; Zhou Y; Wong DF; Workman CI
Neurobiol Dis; 2017 Sep; 105():33-41. PubMed ID: 28511918
[TBL] [Abstract][Full Text] [Related]
13. Association between white matter lesions and cerebral Aβ burden.
Yi HA; Won KS; Chang HW; Kim HW
PLoS One; 2018; 13(9):e0204313. PubMed ID: 30248123
[TBL] [Abstract][Full Text] [Related]
14. Altered amplitude of low-frequency fluctuations in early and late mild cognitive impairment and Alzheimer's disease.
Liang P; Xiang J; Liang H; Qi Z; Li K; Alzheimer's Disease NeuroImaging Initiative
Curr Alzheimer Res; 2014 May; 11(4):389-98. PubMed ID: 24720892
[TBL] [Abstract][Full Text] [Related]
15. Poor awareness of IADL deficits is associated with reduced regional brain volume in older adults with cognitive impairment.
Steward KA; Kennedy R; Erus G; Nasrallah IM; Wadley VG
Neuropsychologia; 2019 Jun; 129():372-378. PubMed ID: 31059694
[TBL] [Abstract][Full Text] [Related]
16. Pattern of regional white matter hyperintensity volume in mild cognitive impairment subtypes and associations with decline in daily functioning.
Bangen KJ; Thomas KR; Weigand AJ; Sanchez DL; Delano-Wood L; Edmonds EC; Carmichael OT; Schwarz CG; Brickman AM; Bondi MW;
Neurobiol Aging; 2020 Feb; 86():134-142. PubMed ID: 31791658
[TBL] [Abstract][Full Text] [Related]
17. Aberrant vascular architecture in the hippocampus correlates with tau burden in mild cognitive impairment and Alzheimer's disease.
Lee H; Fu JF; Gaudet K; Bryant AG; Price JC; Bennett RE; Johnson KA; Hyman BT; Hedden T; Salat DH; Yen YF; Huang SY
J Cereb Blood Flow Metab; 2024 May; 44(5):787-800. PubMed ID: 38000018
[TBL] [Abstract][Full Text] [Related]
18. Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease.
Bilello M; Doshi J; Nabavizadeh SA; Toledo JB; Erus G; Xie SX; Trojanowski JQ; Han X; Davatzikos C
J Alzheimers Dis; 2015; 48(4):987-94. PubMed ID: 26402108
[TBL] [Abstract][Full Text] [Related]
19. Effect of mild cognitive impairment and APOE genotype on resting cerebral blood flow and its association with cognition.
Wierenga CE; Dev SI; Shin DD; Clark LR; Bangen KJ; Jak AJ; Rissman RA; Liu TT; Salmon DP; Bondi MW
J Cereb Blood Flow Metab; 2012 Aug; 32(8):1589-99. PubMed ID: 22549621
[TBL] [Abstract][Full Text] [Related]
20. White Matter Lesions in Mild Cognitive Impairment and Idiopathic Parkinson's Disease: Multimodal Advanced MRI and Cognitive Associations.
Rane S; Owen J; Hippe DS; Cholerton B; Zabetian CP; Montine T; Grabowski TJ
J Neuroimaging; 2020 Nov; 30(6):843-850. PubMed ID: 32937003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
